Skip to main content
. 2018 Nov 8;22(6):407–414. doi: 10.1080/19768354.2018.1494628

Figure 2.

Figure 2.

Cell viability of TM3 Leydig cells treated Taraxacum officinale extract. The varying concentration of 0, 1, 10, 25 and 50 µg/ml of T. officinale were treated into TM3 cells for 24(A) and 48 h(B). The experiments were performed in triplicate.